| |
| |
|
| Insider
Information: |
Eldridge George A |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,960 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,960 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aerovate Therapeutics, Inc. |
AVTE |
|
2024-04-10 |
1,960 |
2022-11-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-04-10 |
4 |
AS |
$26.77 |
$201,392 |
D/D |
(7,500) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-04-10 |
4 |
OE |
$2.14 |
$16,050 |
D/D |
7,500 |
9,460 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-04-01 |
4 |
AS |
$31.23 |
$390,208 |
D/D |
(12,495) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-04-01 |
4 |
OE |
$2.14 |
$26,739 |
D/D |
12,495 |
14,455 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-13 |
4 |
AS |
$25.02 |
$50,445 |
D/D |
(2,016) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-13 |
4 |
OE |
$2.14 |
$4,314 |
D/D |
2,016 |
3,976 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-12 |
4 |
AS |
$25.05 |
$51,370 |
D/D |
(2,051) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-12 |
4 |
OE |
$2.14 |
$4,389 |
D/D |
2,051 |
4,011 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-11 |
4 |
OE |
$2.14 |
$7,347 |
D/D |
3,433 |
5,393 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-11 |
4 |
AS |
$25.24 |
$86,667 |
D/D |
(3,433) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-08 |
4 |
AS |
$25.00 |
$2,850 |
D/D |
(114) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-08 |
4 |
OE |
$2.14 |
$244 |
D/D |
114 |
2,074 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-07 |
4 |
AS |
$25.00 |
$559,688 |
D/D |
(22,386) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2024-03-07 |
4 |
OE |
$2.14 |
$47,906 |
D/D |
22,386 |
24,346 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-12 |
4 |
AS |
$30.04 |
$300,428 |
D/D |
(10,000) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-12 |
4 |
OE |
$2.14 |
$21,400 |
D/D |
10,000 |
11,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-09 |
4 |
AS |
$24.23 |
$96,765 |
D/D |
(3,969) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-09 |
4 |
OE |
$2.14 |
$8,494 |
D/D |
3,969 |
5,929 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-08 |
4 |
AS |
$20.12 |
$286,700 |
D/D |
(12,011) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-08 |
4 |
OE |
$2.14 |
$25,704 |
D/D |
12,011 |
13,971 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-07 |
4 |
AS |
$19.37 |
$230,083 |
D/D |
(11,637) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-12-07 |
4 |
OE |
$2.14 |
$24,903 |
D/D |
11,637 |
13,597 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-11-30 |
4 |
AS |
$19.06 |
$1,620 |
D/D |
(85) |
1,960 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-11-30 |
4 |
OE |
$2.14 |
$182 |
D/D |
85 |
2,045 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
SEE REMARKS |
• – – |
2022-11-23 |
4 |
OE |
$2.14 |
$2,699 |
D/D |
1,261 |
3,221 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
